Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,111 | 288 | 98.7% |
| Education | $67.00 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,749 | 107 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $603.18 | 36 | $0 (2024) |
| Boston Scientific Corporation | $327.81 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $290.26 | 14 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $250.10 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $219.30 | 13 | $0 (2024) |
| PFIZER INC. | $171.16 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $161.97 | 8 | $0 (2022) |
| GENZYME CORPORATION | $140.29 | 8 | $0 (2024) |
| Celgene Corporation | $132.94 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,164 | 74 | ABBVIE INC. ($209.10) |
| 2023 | $1,177 | 67 | AbbVie Inc. ($328.11) |
| 2022 | $1,445 | 68 | ABBVIE INC. ($684.31) |
| 2021 | $1,157 | 66 | AbbVie Inc. ($437.01) |
| 2020 | $234.78 | 14 | AbbVie Inc. ($90.12) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/06/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: VIROLOGY | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: LIVER DISEASE | ||||||
| 11/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: LIVER DISEASE | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.84 | General |
| 10/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/11/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 10/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/24/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 756 | 937 | $449,658 | $79,194 |
| 2022 | 22 | 805 | 912 | $545,459 | $72,269 |
| 2021 | 18 | 667 | 782 | $452,262 | $64,677 |
| 2020 | 11 | 260 | 283 | $120,346 | $21,576 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 79 | $96,707 | $15,412 | 15.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 58 | $18,890 | $7,630 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 88 | $18,623 | $7,402 | 39.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 79 | $15,637 | $7,134 | 45.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 66 | 66 | $71,802 | $6,012 | 8.4% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 15 | 16 | $20,106 | $5,205 | 25.9% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 25 | 28 | $29,728 | $4,747 | 16.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 33 | 46 | $24,978 | $4,725 | 18.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 51 | $29,899 | $4,062 | 13.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 60 | 63 | $40,613 | $3,749 | 9.2% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 18 | $17,118 | $3,169 | 18.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 13 | $9,172 | $2,177 | 23.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $9,156 | $2,173 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 26 | $3,900 | $1,777 | 45.6% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $7,469 | $1,696 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 64 | $945.00 | $537.60 | 56.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 112 | 125 | $18,081 | $491.14 | 2.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 42 | $925.00 | $434.70 | 47.0% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 16 | 16 | $15,474 | $419.84 | 2.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 11 | 21 | $252.00 | $133.14 | 52.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 13 | 14 | $183.00 | $106.54 | 58.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 84 | 85 | $103,967 | $16,208 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 88 | $18,387 | $7,837 | 42.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 43 | $14,835 | $6,491 | 43.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 75 | $87,048 | $5,679 | 6.5% |
About Dr. Brandon Dickinson, M.D
Dr. Brandon Dickinson, M.D is a Gastroenterology healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1770825713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandon Dickinson, M.D has received a total of $5,178 in payments from pharmaceutical and medical device companies, with $1,164 received in 2024. These payments were reported across 289 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,111).
As a Medicare-enrolled provider, Dickinson has provided services to 2,488 Medicare beneficiaries, totaling 2,914 services with total Medicare billing of $237,716. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Provo, UT
- Active Since 03/17/2013
- Last Updated 11/27/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1770825713
Products in Payments
- ENTYVIO (Biological) $479.91
- HUMIRA (Biological) $477.04
- RINVOQ (Biological) $377.12
- CREON (Drug) $280.24
- ZENPEP (Drug) $275.56
- STELARA (Biological) $253.79
- SKYRIZI (Biological) $253.77
- LINZESS (Drug) $237.03
- DUPIXENT (Biological) $219.24
- XELJANZ (Drug) $171.16
- INJECTAFER (Drug) $161.97
- Axios (Device) $141.94
- ZEPOSIA (Drug) $132.94
- OCALIVA (Drug) $132.89
- EXALT Model D (Device) $120.92
- XIFAXAN (Drug) $119.83
- MAVYRET (Drug) $93.05
- RENFLEXIS (Drug) $89.26
- TRULANCE (Drug) $81.21
- RESMETIROM (Drug) $68.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Provo
Brett Thorpe, Md, MD
Gastroenterology — Payments: $13,783
Kurt Bodily, Md, MD
Gastroenterology — Payments: $10,960
Thomas Dickinson, Md, MD
Gastroenterology — Payments: $6,132
Dr. Clarke Hilbig, M.d, M.D
Gastroenterology — Payments: $3,412
Gregory Craner, Md, MD
Gastroenterology — Payments: $15.13